Sun Pharmaceutical Industries reports marginal rise in Q3 consolidated net profit

31 Jan 2023 Evaluate

Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2022.

The company has reported fall of 5.57% in its net profit at Rs 486.73 crore for Q3FY23 as compared to Rs 515.43 crore for the corresponding quarter previous year. However, total income of the company increased by 15.65% to Rs 4,713.78 crore for the quarter under review as compared to Rs 4,075.89 crore for the same quarter in the previous year.

On the consolidated basis, the company has reported rise of 2.69% in its net profit at Rs 2,188.04 crore for Q3FY23 as compared to Rs 2,130.80 crore for the same quarter in the previous year. However, total income of the company increased by 10.87% to Rs 11,414.85 crore for the quarter under review as compared to Rs 10,295.57 crore for the same quarter in the previous year.

Sun Pharma Inds. Share Price

1631.65 -2.75 (-0.17%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×